LARGE may also have a therapeutic role in dystroglycanopathies, as its overexpression can stimulate increased glycosylation of αDG even in disorders where other genes in the pathway are mutated22. This evidence concerns the gene LARGE1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.